| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0024-3205(96)00502-4 |
| P698 | PubMed publication ID | 9000640 |
| P2093 | author name string | M A Liu | |
| J B Ulmer | |||
| J J Donnelly | |||
| P2860 | cites work | DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid | Q27480298 |
| Immune responses to plasmid DNA encoding the hepatitis C virus core protein | Q27480300 | ||
| Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity | Q29619700 | ||
| Protection against mycoplasma infection using expression-library immunization | Q34296157 | ||
| DNA vaccination against persistent viral infection. | Q35838136 | ||
| Protection against Mycoplasma pulmonis infection by genetic vaccination | Q36688812 | ||
| Replication of hepatitis delta virus RNA in mice after intramuscular injection of plasmid DNA | Q39871373 | ||
| Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. | Q40047174 | ||
| Towards a DNA vaccine against tuberculosis. | Q40605760 | ||
| Immunization with DNA. | Q40645351 | ||
| A genetic approach to idiotypic vaccination for B cell lymphoma | Q40937655 | ||
| Nucleic acid malaria vaccines. Current status and potential | Q40937696 | ||
| Induction of Humoral and Cellular Immune Responses to the Human Immunodeficiency Type 1 Virus in Nonhuman Primates by in Vivo DNA Inoculation | Q41317048 | ||
| Immune responses to nucleic acid vaccines to rabies virus | Q41337967 | ||
| Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice. | Q41346392 | ||
| Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. | Q41487464 | ||
| DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody | Q41516107 | ||
| Cytotoxic T lymphocyte and helper T cell responses following HIV polynucleotide vaccination | Q43809587 | ||
| Gene transfer into somatic tissues by jet injection | Q43819418 | ||
| Heterologous protection against influenza by injection of DNA encoding a viral protein | Q43828996 | ||
| Genetic immunization is a simple method for eliciting an immune response | Q43857336 | ||
| Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV type 1 env and rev gene products | Q44119971 | ||
| Immunization with plasmid DNA using a pneumatic gun. | Q44475853 | ||
| Genetic vaccination against leishmaniasis | Q45026373 | ||
| Neutralization of CRPV infectivity by monoclonal antibodies that identify conformational epitopes on intact virions | Q45217723 | ||
| Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge | Q45771710 | ||
| DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates | Q45777945 | ||
| Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines | Q45783780 | ||
| Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus | Q45788449 | ||
| Gene Transfer into Mammalian Cells by Jet Injection | Q45867523 | ||
| Protection against malaria by immunization with a Plasmodium yoelii circumsporozoite protein nucleic acid vaccine | Q48007496 | ||
| Induction of antibodies against Salmonella typhi OmpC porin by naked DNA immunization. | Q50141631 | ||
| Jet-injected insulin is associated with decreased antibody production and postprandial glucose variability when compared with needle-injected insulin in gestational diabetic women. | Q51598312 | ||
| Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. | Q54649033 | ||
| Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation | Q59062494 | ||
| Plasmid vectors as anti-viral vaccines | Q70858361 | ||
| Protection against papillomavirus with a polynucleotide vaccine | Q70916613 | ||
| Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA | Q70944351 | ||
| Antibodies to Schistosoma japonicum (Asian bloodfluke) paramyosin induced by nucleic acid vaccination | Q71935128 | ||
| Long-Term Anti-Nucleoprotein Cellular and Humoral Immunity Is Induced by Intramuscular Injection of Plasmid DNA Containing NP Gene | Q72100764 | ||
| Improved specificity of in vitro anti-HIV antibody production: implications for diagnosis and timing of transmission in infants born to HIV-seropositive mothers | Q72160013 | ||
| Generation of allo-reactive cytotoxic T lymphocytes by particle bombardment-mediated gene transfer | Q72468446 | ||
| Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin | Q72603683 | ||
| A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine | Q72625630 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 163-172 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | Life Sciences | Q5256275 |
| P1476 | title | DNA vaccines | |
| P478 | volume | 60 |
| Q35809245 | Attenuated salmonella and Shigella as carriers for DNA vaccines |
| Q40948095 | Biodegradable alginate microspheres as a delivery system for naked DNA. |
| Q34611897 | Bovine herpesvirus glycoprotein D: a review of its structural characteristics and applications in vaccinology |
| Q35126948 | C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis |
| Q34978592 | Cationic microparticles: A potent delivery system for DNA vaccines |
| Q21284428 | Combination of apigenin treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic antitumor effects |
| Q37038302 | Combination of treatment with death receptor 5-specific antibody with therapeutic HPV DNA vaccination generates enhanced therapeutic anti-tumor effects |
| Q33876144 | Construction and immunogenicity of a DNA vaccine coexpressing GP3 and GP5 of genotype-I porcine reproductive and respiratory syndrome virus |
| Q33589123 | Current paradoxes and changing paradigms in vaccinology |
| Q34306673 | DNA immunization and central nervous system viral infection |
| Q33784641 | DNA immunization with minigenes: low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination |
| Q36828240 | DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity. |
| Q33912001 | DNA vaccination against influenza viruses: a review with emphasis on equine and swine influenza |
| Q40430455 | DNA vaccination for the priming of neutralizing antibodies against non-immunogenic STa enterotoxin from enterotoxigenic Escherichia coli |
| Q82378199 | DNA vaccination targeting macrophage migration inhibitory factor prevents murine experimental colitis |
| Q35148074 | DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells |
| Q40062129 | DNA vaccines against leptospirosis: A literature review. |
| Q33843297 | DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge |
| Q36491901 | DNA-based vaccination induces humoral and cellular immune responses against hepatitis B virus surface antigen in mice without activation of C-myc |
| Q47874912 | Differences in epitope recognition, isotype and titer of antisera to Plasmodium falciparum merozoite surface protein 4 raised by different modes of DNA or protein immunization |
| Q33873715 | Direct ex vivo kinetic and phenotypic analyses of CD8(+) T-cell responses induced by DNA immunization |
| Q37239807 | Effect of GPI anchor moiety on the immunogenicity of DNA plasmids encoding the 19-kDa C-terminal portion of Plasmodium falciparum MSP-1. |
| Q81792807 | Electroporation-based DNA transfer enhances gene expression and immune responses to DNA vaccines in cattle |
| Q30735542 | Eliciting an immune response by plasmid DNA encoding a human sperm protein (HSD-1). |
| Q35826661 | Elucidating the Kinetics of Expression and Immune Cell Infiltration Resulting from Plasmid Gene Delivery Enhanced by Surface Dermal Electroporation |
| Q51823026 | Encapsulation of protamine sulphate compacted DNA in polylactide and polylactide-co-glycolide microparticles. |
| Q36851838 | Enhanced immune response against HIV-1 induced by a heterologous DNA prime-adenovirus boost vaccination using mannosylated polyethyleneimine as DNA vaccine adjuvant. |
| Q40941953 | Enhanced protection against viral infection by co-administration of plasmid DNA coding for viral antigen and cytokines in mice |
| Q34766642 | Enhancement of CD4+ T-cell help reverses the doxorubicin-induced suppression of antigen-specific immune responses in vaccinated mice |
| Q41034921 | Enhancing immune responses using suicidal DNA vaccines. |
| Q39606955 | Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors. |
| Q45864659 | Gene gun-mediated DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs |
| Q34131388 | Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection |
| Q30947127 | Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection |
| Q45467459 | Genetic immunization with codon-optimized equine infectious anemia virus (EIAV) surface unit (SU) envelope protein gene sequences stimulates immune responses in ponies |
| Q45871042 | Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx mice |
| Q36438213 | Immune response to a hepatitis B DNA vaccine in Aotus monkeys: a comparison of vaccine formulation, route, and method of administration |
| Q40718599 | Immunization of livestock with DNA vaccines: current studies and future prospects |
| Q42798830 | Immunization with DNA, adenovirus or both in biodegradable alginate microspheres: effect of route of inoculation on immune response |
| Q45405213 | Immunogenicity of hybrid DNA vaccines expressing hepatitis B core particles carrying human and simian immunodeficiency virus epitopes in mice and rhesus macaques. |
| Q47805031 | Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model |
| Q57240638 | Influence of glycosylphosphatidylinositol anchorage on the efficacy of DNA vaccines encoding Plasmodium yoelii merozoite surface protein 4/5 |
| Q40824275 | Membrane bound Indian clade C HIV-1 envelope antigen induces antibodies to diverse and conserved epitopes upon DNA prime/protein boost in rabbits. |
| Q34343274 | Microparticles for intranasal immunization |
| Q45890312 | Modulation of alloimmunity to major histocompatibility complex class I by cotransfer of cytokine genes in vivo. |
| Q30470709 | Molecular medicine's applications to the developing world: enlightened self interest |
| Q57160398 | Multi-plasmid DNA vaccination avoids antigenic competition and enhances immunogenicity of a poorly immunogenic plasmid |
| Q35896155 | Neonatal DNA immunization with a plasmid encoding an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge. |
| Q33591527 | New vaccines against tuberculosis. The status of current research |
| Q77962035 | Novel vaccination protocol consisting of injecting MUC1 DNA and nonprimed dendritic cells at the same region greatly enhanced MUC1-specific antitumor immunity in a murine model |
| Q41629004 | Plasmid DNA expression systems for the purpose of immunization |
| Q34447825 | Plasmid DNA vaccines. Immunology, tolerance, and autoimmunity |
| Q77157796 | Plasmid DNA: a new era in vaccinology |
| Q37805248 | Poly-N-acetyl glucosamine gel matrix as a non-viral delivery vector for DNA-based vaccination |
| Q36602269 | Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases |
| Q34732544 | Pretreatment with cisplatin enhances E7-specific CD8+ T-Cell-mediated antitumor immunity induced by DNA vaccination |
| Q36331993 | Rationale and perspectives on the success of vaccination against bovine herpesvirus-1. |
| Q40974795 | Recombinant Invasive Lactococcus lactis Carrying a DNA Vaccine Coding the Ag85A Antigen Increases INF-γ, IL-6, and TNF-α Cytokines after Intranasal Immunization |
| Q37550619 | Skin Transfection Patterns and Expression Kinetics of Electroporation-Enhanced Plasmid Delivery Using the CELLECTRA-3P, a Portable Next-Generation Dermal Electroporation Device |
| Q44361219 | The effect of CTAB concentration in cationic PLG microparticles on DNA adsorption and in vivo performance |
| Q33797354 | The potential use of heat-shock proteins to vaccinate against mycobacterial infections |
| Q43682896 | The preparation, characterization, and evaluation of cationic microparticles for DNA vaccine delivery. |
| Q41712102 | The role of CpG dinucleotides in DNA vaccines |
| Q28481573 | Therapeutic DNA vaccine induces broad T cell responses in the gut and sustained protection from viral rebound and AIDS in SIV-infected rhesus macaques |
| Q33936427 | Therapeutic HPV DNA vaccines |
| Q33864400 | Treatment with imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination |
| Q36874310 | Treatment with proteasome inhibitor bortezomib enhances antigen-specific CD8+ T-cell-mediated antitumor immunity induced by DNA vaccination |
| Q39549251 | Two-helper RNA system for production of recombinant Semliki forest virus particles. |
| Q43505013 | Uptake of microparticles into the epithelium of human nasopharyngeal lymphoid tissue |
| Q37547365 | Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag |
| Q33991804 | Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial |
| Q34708423 | Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines |
| Q37127506 | Vaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infection |
Search more.